Announcement on Resignation of Directors
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
Announcement on Resignation of Directors
Filed with SSE ·
6ix hasn’t read this filing yet.
CABIO Biotech (Wuhan) Co. Ltd. on 6ix
Earlier from CABIO Biotech (Wuhan)
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on Implementation Result of Phase II Shares Repurchase and Share Changes
- Announcement on Progress in Repurchasing Shares through Call Auction in Phase II
- Announcement on Closing Some Investment Projects Financed by Raised Funds, Using Residual Raised Funds to Permanently Supplement Current Capital, and Cancellation of Related Special Account for Raised Funds
- Announcement on Convening the Q3 2025 Performance Briefing
Later from CABIO Biotech (Wuhan)
- Special Report on Deposit and Actual Use of Raised Funds in 2025
- Announcement on Participating in the SSE STAR Market's 2025 Annual Biological Products Industry Collective Performance Briefing and the Q1 2026 Performance Briefing
- Notice on Convening the 2025 Annual General Meeting
- Announcement on Voluntary Disclosure of the Approval of Lacto-N-neotetraose
- Announcement on Resolutions of the 2025 Annual General Meeting
Follow CABIO Biotech (Wuhan) into a list and get an email when it puts out news.
Follow CABIO Biotech (Wuhan)